Design Therapeutics (DSGN) Q3 2026 Earnings

3AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Q3 2026
-0.34
-0.33
-0.31
-0.29

Details

Expected EPS
-0.344286
Actual EPS
-0.32
Surprise EPS
0.02
Surprise Percent
+7.05%

Description

Design Therapeutics (DSGN) has reported earnings of -0.32 per share for Q3 2026.

0 Comments

Share your thoughts